Comparisons Of Efficacy And Safety Of Oral Semaglutide And Injectable Liraglutide Or Semaglutide To determine efficacy and safety of oral semaglutide as monotherapy, the 26-week, phase 3, double-blinded, placebo-controlled RCT (PIONEER-1) primarily aimed to demonstrate glycemic superiority of once-daily oral semaglutide against placebo in 703 T2D adults with mean age of 5511 years, BMI of 31.86.6 kg/m 2 , baseline HbA1c of 8.00.7% (638 mmol/mol), and diabetes duration of 3.5 years
B., Twiss, I
However, relying solely on this method and its current interpretation chart would in our setting have led to unclear genotype assignment (1/1b, but 6 not excluded) in 15% of the samples and underestimation of genotype 6 prevalence
doi: 10.1016/j.neubiorev.2019.08.021 45 WaddenTAHollanderPKleinSNiswenderKWooVHalePMet al
A revocation does not affect the validity of past data processing operations.
Metabolism GLP-1 gets rapidly metabolized in the circulation by dipeptidyl peptidase-4 (DPP-IV), resulting in a short plasma half-life of approximately 2 min [11]